Aptamer Group

Aptamer Group is a UK-based biotechnology company that develops custom aptamer reagents and solutions for diagnostics, therapeutics, and research applications. Founded in 2008, the company leverages its proprietary Optimer® platform to create synthetic affinity ligands designed to outperform traditional antibodies. It partners with global pharmaceutical, diagnostic, and biotech companies to accelerate drug discovery, clinical development, and bioprocessing.